A Study of SEA-CD40 Given With Other Drugs in Cancers
Status:
Recruiting
Trial end date:
2025-10-31
Target enrollment:
Participant gender:
Summary
This trial is being done to see if an experimental drug (SEA-CD40) works when it's given with
other cancer drugs to treat some types of cancer. It will also study side effects from the
drug.
There are 2 parts in this trial. In one part, participants have melanoma that has come back
after treatment or can't be removed by surgery. Participants in this part will get SEA-CD40
and pembrolizumab. In the other part, participants have non-small cell lung cancer (NSCLC)
that has spread through their body. These participants will get SEA-CD40, pembrolizumab,
carboplatin, and pemetrexed.